Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › LRMR

DEERFIELD MANAGEMENT COMPANY, L.P. position in LRMR

Larimar Therapeutics Inc · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 35,606,974 shares of LRMR (Larimar Therapeutics Inc) in its Q2 2026 13F filing — a position valued at US$108.6M, representing 1.36% of its reported portfolio and ranking #21 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)35.61M sh
Reported value held$108.60M
Portfolio Weight1.36%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s LRMR position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in LRMR in Q3 2023 at 16,941,357 shares (US$66.9M). The position peaked in Q1 2024 at 21,231,974 shares, worth US$161.2M. Across 12 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 35,606,974 shares valued at US$108.6M. Notable position changes include a 25% increase in Q1 2024 (shares fell 4% over the following quarter), a 44% increase in Q3 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.94M $66.92M New
Q4 2023 16.94M $77.08M Hold
Q1 2024 21.23M $161.15M Add
Q2 2024 21.23M $153.93M Hold
Q3 2024 21.23M $139.07M Hold
Q4 2024 21.23M $82.17M Hold
Q1 2025 21.23M $45.65M Hold
Q2 2025 21.23M $61.36M Hold
Q3 2025 30.61M $98.86M Add
Q4 2025 30.61M $116.61M Hold
Q1 2026 35.61M $160.23M Add
Q2 2026 35.61M $108.60M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LRMR and 13F data

LRMR (Larimar Therapeutics Inc) is a Health Care company. 25 other funds we track also report a position in LRMR — the largest reported positions include Defilade Capital Management, L.P. (US$11.2M), DAFNA Capital Management LLC (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LRMR

All LRMR fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held LRMR?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in LRMR?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 35.61M shares of LRMR (Larimar Therapeutics Inc), valued at $108.60M, representing 1.36% of its reported portfolio and ranking #21.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling LRMR?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in LRMR. The position peaked in Q1 2024 at 21.23M shares.

Which other funds hold LRMR?

Other major institutional holders of LRMR include Defilade Capital Management, L.P., DAFNA Capital Management LLC, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.